Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annika Nelde

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Nature Communications|March 6, 2025
Author Correction: Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profilingLisa Bertrand, Annika Nelde, Bertha Cecilia Ramirez, et al.
Nature Communications|February 18, 2025
Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profilingLisa Bertrand, Annika Nelde, Bertha Cecilia Ramirez, et al.
Nature Communications|February 20, 2021
Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivityMatthias Becker, Monika Strengert, Daniel Junker, et al.
ACS Sensors|January 26, 2021
Magnetic Bead-Based Immunoassay Allows Rapid, Inexpensive, and Quantitative Detection of Human SARS-CoV-2 AntibodiesLuciano F Huergo, Khaled A Selim, Marcelo S Conzentino, et al.
Cancer Research|October 3, 2025
FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid LeukemiaMelissa Zwick, Bastian Zinkel, Corinna Spohr, et al.
Nature Communications|August 18, 2023
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiencyJonas S Heitmann, Claudia Tandler, Maddalena Marconato, et al.
Nature Immunology|October 1, 2020
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognitionAnnika Nelde, Tatjana Bilich, Jonas S Heitmann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2022
Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron VariantsDaniel Junker, Matthias Becker, Teresa R Wagner, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Nature Communications|March 6, 2025
Author Correction: Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profilingLisa Bertrand, Annika Nelde, Bertha Cecilia Ramirez, et al.
Nature Communications|February 18, 2025
Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profilingLisa Bertrand, Annika Nelde, Bertha Cecilia Ramirez, et al.
Nature Communications|February 20, 2021
Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivityMatthias Becker, Monika Strengert, Daniel Junker, et al.
ACS Sensors|January 26, 2021
Magnetic Bead-Based Immunoassay Allows Rapid, Inexpensive, and Quantitative Detection of Human SARS-CoV-2 AntibodiesLuciano F Huergo, Khaled A Selim, Marcelo S Conzentino, et al.
Cancer Research|October 3, 2025
FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid LeukemiaMelissa Zwick, Bastian Zinkel, Corinna Spohr, et al.
Nature Communications|August 18, 2023
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiencyJonas S Heitmann, Claudia Tandler, Maddalena Marconato, et al.
Nature Immunology|October 1, 2020
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognitionAnnika Nelde, Tatjana Bilich, Jonas S Heitmann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2022
Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron VariantsDaniel Junker, Matthias Becker, Teresa R Wagner, et al.
Pageof 6